Differences in metabolic and mitogenic signalling of insulin glargine and insulin aspart B10 in rats
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0428
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Differences in metabolic and mitogenic signalling of insulin glargine and insulin aspart B10 in rats ; volume:56 ; number:8 ; day:8 ; month:5 ; year:2013 ; pages:1826-1834 ; date:8.2013
Diabetologia ; 56, Heft 8 (8.5.2013), 1826-1834, 8.2013
- Urheber
-
Tennagels, N.
Welte, S.
Hofmann, M.
Brenk, P.
Schmidt, R.
Werner, U.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00125-013-2923-z
- URN
-
urn:nbn:de:101:1-2021080707312306458816
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tennagels, N.
- Welte, S.
- Hofmann, M.
- Brenk, P.
- Schmidt, R.
- Werner, U.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function
Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients
MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Host insulin stimulates Echinococcus multilocularis insulin signalling pathways and larval development
Comparison between Insulin Glargine and Insulin Detemir in Adolescents with Type 1 Diabetes during Ramadan Fasting
Crossregulation of Insulin signalling and innate immunity
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)
Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study
Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
The efficacy of insulin degludec and insulin glargine over NPH insulin among toddlers and preschoolers with type 1 diabetes using glycemic variability and time in range
Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function
Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients
MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Host insulin stimulates Echinococcus multilocularis insulin signalling pathways and larval development
Comparison between Insulin Glargine and Insulin Detemir in Adolescents with Type 1 Diabetes during Ramadan Fasting
Crossregulation of Insulin signalling and innate immunity
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)
Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study
Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
The efficacy of insulin degludec and insulin glargine over NPH insulin among toddlers and preschoolers with type 1 diabetes using glycemic variability and time in range
Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function
Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients
MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Host insulin stimulates Echinococcus multilocularis insulin signalling pathways and larval development
Comparison between Insulin Glargine and Insulin Detemir in Adolescents with Type 1 Diabetes during Ramadan Fasting
Crossregulation of Insulin signalling and innate immunity
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)
Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study
Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus